fresh
lung
explant
obtain
patient
undergo
lung
resect
thorac
surgeri
center
berlin
written
inform
consent
obtain
patient
studi
approv
ethic
committe
clinic
project
tumorfre
normal
lung
tissu
immedi
stamp
small
cylind
height
diamet
mm
incub
roswel
park
memori
institut
medium
contain
bovin
serum
albumin
mm
lglutamin
antibiot
overnight
incub
lung
organ
cultur
inocul
plaqueform
unit
pfu
viru
hour
follow
wash
step
phosphatebuff
salin
remov
excess
viru
growthcurv
analysi
supernat
titrat
madindarbi
canin
kidney
mdck
cell
standard
plaqu
assay
describ
elsewher
mdck
cell
grown
minimum
essenti
medium
contain
fetal
calf
serum
mm
lglutamin
antibiot
virus
use
studi
includ
hpaiv
strain
isol
fatal
human
case
pandem
strain
season
anew
strain
lowpathogen
avian
viru
dkalb
strain
classic
swine
viru
swwi
strain
tabl
use
recombin
version
influenza
strain
gener
revers
genet
describ
elsewher
human
viru
strain
grown
mdck
cell
wherea
duck
swine
isol
propag
embryon
chicken
egg
viru
stock
aliquot
store
titrat
mdck
cell
plaqu
assay
experi
viru
perform
biosafeti
level
contain
laboratori
approv
local
author
work
virus
lung
tissu
fix
paraformaldehyd
sigma
deparaffin
tissu
section
heat
citrat
buffer
mm
sodium
citrat
ph
minut
antigen
retriev
permeabil
minut
slide
block
adequ
serum
minut
incub
dilut
alexa
fluor
influenza
antibodi
serotec
overnight
influenza
virion
antibodi
label
use
dylight
microscal
antibodi
label
kit
thermo
scientif
desir
sialic
acid
detect
vector
red
stain
lectin
tissu
section
incub
overnight
primari
antibodi
prosurfact
protein
c
chemicon
sigma
andor
abcam
respect
afterward
slide
incub
correspond
alexa
alexa
secondari
antibodi
invitrogen
mount
mowiol
analyz
lsm
pascal
confoc
microscop
object
planneofluaroil
na
planapochromatoil
na
zeiss
jena
germani
human
lung
explant
infect
viru
hour
subsequ
fix
immers
glutaraldehyd
mm
hepe
postfix
hour
tannic
acid
mm
hepe
minut
uranyl
acet
hour
sampl
dehydr
grade
ethanol
embed
epon
resin
thin
section
cut
use
ultramicrotom
ultracut
leica
wetzlar
germani
counterstain
uranyl
acet
minut
lead
citrat
minut
section
examin
tem
microscop
carl
zeiss
smt
ag
imag
digit
use
slowscan
chargecoupleddevic
camera
pro
scan
scheur
germani
concentr
supernat
infect
lung
explant
determin
procarta
cytokin
assay
kit
panom
inactiv
viru
incub
tnbptriton
interferon
interleukin
level
supernat
analyz
use
commerci
enzymelink
immunosorb
assay
kit
fujirebio
tokyo
bd
bioscienc
heidelberg
systemat
compar
replic
human
anim
influenza
virus
tabl
human
lung
establish
ex
vivo
explant
model
lung
specimen
mainli
consist
complex
alveolar
tissu
deriv
lower
pulmonari
lobe
figur
infect
explant
prototyp
season
viru
result
product
infect
strong
increas
number
infecti
viral
particl
cultur
supernat
figur
viabil
specimen
remain
stabl
hour
judg
constantli
low
valu
releas
lactat
dehydrogenas
data
shown
henc
infect
explant
donor
hour
day
later
result
minor
differ
viral
growth
curv
figur
addit
trypsin
increas
viru
titer
suggest
proteas
activ
requir
cleavag
activ
viral
ha
preserv
lung
explant
data
shown
systemat
comparison
replic
effici
reveal
remark
reproduc
differ
strain
season
highli
pathogen
virus
propag
effici
wherea
lowpathogen
avian
dkalb
viru
replic
order
magnitud
lower
figur
similarli
season
pandem
virus
replic
compar
titer
growth
classic
swine
influenza
viru
swwi
significantli
attenu
figur
observ
differ
unlik
result
specif
receptor
prefer
lectin
histochem
analysi
identifi
receptor
determin
alveolar
compart
supplementari
figur
confirm
previou
report
overal
data
demonstr
substanti
differ
growth
capac
human
anim
influenza
virus
human
lung
tissu
interestingli
appear
correl
abil
differ
influenza
virus
replic
explant
capac
caus
lower
respiratori
tract
infect
human
observ
growth
restrict
porcin
lowpathogen
avian
influenza
virus
could
caus
sever
factor
includ
lack
initi
infect
low
viral
gene
express
strong
activ
innat
immun
respons
differ
cellular
tropism
identifi
possibl
differ
human
anim
viru
strain
cellular
level
infect
human
lung
explant
perform
immunohistochem
analys
figur
despit
poor
propag
human
lung
tissu
viral
antigen
detect
cell
infect
lowpathogen
avian
classic
swine
viru
similar
rate
interestingli
costain
virion
antigen
type
ii
marker
surfact
protein
c
precursor
reveal
vast
major
cell
infect
swwi
dkalb
viru
repres
type
ii
pneumocyt
figur
convers
fail
detect
virus
type
pneumocyt
judg
costain
marker
antigen
figur
caveolin
data
shown
although
lectin
stain
confirm
presenc
receptor
human
avian
strain
pneumocyt
type
figur
doubl
stain
viral
antigen
marker
also
detect
influenza
viru
alveolar
macrophag
virus
test
supplementari
figur
like
indic
ongo
infect
macrophag
influenza
cell
detect
incub
ultraviolet
light
uv
virus
data
shown
although
exclud
part
signal
caus
phagocytos
viral
antigen
quantif
infect
cell
type
tissu
cross
section
show
alveolar
macrophag
account
antigenposit
cell
wherea
type
ii
pneumocyt
depend
viru
strain
figur
evalu
immunohistochem
data
regard
cellular
tropism
ultrastructur
level
lung
explant
infect
process
transmiss
electron
microscopi
figur
depict
alveolar
epitheli
cell
lung
explant
hour
infect
bud
viru
particl
observ
apic
side
cell
identifi
type
ii
pneumocyt
typic
presenc
surfactantfil
multilamellar
bodi
figur
none
specimen
observ
viru
bud
cell
hallmark
type
pneumocyt
data
show
human
anim
influenza
virus
share
cell
tropism
type
ii
pneumocyt
human
lung
tissu
although
remark
differ
capac
propag
cell
unclear
whether
enhanc
cytokin
level
observ
patient
mice
deriv
mainli
primarili
infect
epitheli
cell
alveolar
macrophag
recruit
immun
cell
thu
determin
induct
cytokin
lung
tissu
hpaiv
virus
panel
infect
human
lung
tissu
season
virus
pandem
viru
provok
weak
secret
figur
contrast
viru
elicit
strong
induct
cytokin
chemokin
surprisingli
lowpathogen
avian
viru
dkalb
also
provok
pronounc
induct
cytokin
chemokin
reach
higher
level
observ
season
upregul
hardli
occur
tissu
probe
uvinactiv
viru
allanto
fluid
indic
cytokin
induct
trigger
viral
infect
supplementari
figur
classic
swine
viru
swwi
caus
weak
cytokin
respons
reach
level
significantli
higher
season
virus
conclus
find
indic
avian
influenza
virus
low
pathogen
high
pathogen
induc
consider
stronger
cytokin
respons
alveolar
tissu
humanadapt
virus
even
absenc
recruit
immun
cell
influenza
prime
exampl
major
human
infecti
diseas
origin
anim
reservoir
continu
contribut
viral
gene
gener
novel
human
viru
strain
uniqu
biolog
antigen
properti
influenza
virus
acquir
addit
genet
divers
errorpron
rna
polymeras
rapidli
gener
mutant
variant
select
advantag
new
host
henc
mutat
viral
polymeras
ha
molecul
avian
influenza
virus
known
promot
adapt
mammalian
host
howev
complet
understand
host
factor
facilit
restrict
growth
influenza
virus
human
begin
emerg
one
goal
gain
better
understand
process
associ
adapt
influenza
virus
lower
human
respiratori
tract
strongli
affect
sever
influenza
systemat
compar
tropism
replic
cytokin
induct
influenza
virus
human
avian
porcin
host
explant
human
lung
tissu
suitabl
lung
organ
cultur
studi
support
find
humanadapt
season
pandem
virus
propag
effici
contrast
lowpathogen
avian
classic
swine
virus
replic
poorli
may
reflect
strong
attenu
avian
virus
human
rare
detect
human
patient
swine
influenza
viru
infect
mathemat
model
suggest
specif
cell
tropism
could
strongli
influenc
influenza
sever
fact
differ
target
cell
type
correl
magnitud
replic
avian
human
influenza
virus
reconstitut
human
tracheobronchi
epithelium
similarli
propos
preferenti
infect
type
ii
pneumocyt
virus
human
lung
may
explain
high
viral
load
strong
patholog
respons
patient
nonhuman
primat
suggest
base
fast
metabol
cell
type
essenti
role
maintain
alveolar
surfac
tension
initi
repair
process
howev
immunohistochem
electron
microscopi
analys
explant
lung
tissu
essenc
debilit
hypothesi
examin
virus
show
strong
prefer
infect
type
ii
pneumocyt
although
vari
sever
order
magnitud
progeni
titer
result
confirm
extend
previou
report
detect
viral
antigen
pandem
season
strain
type
ii
pneumocyt
howev
address
product
infecti
viru
particl
cell
type
found
intrigu
least
one
import
respiratori
viral
pathogen
sar
coronaviru
evolv
preferenti
replic
type
ii
pneumocyt
although
clearli
use
differ
receptor
cell
entri
influenza
virus
indic
type
ii
pneumocyt
highli
suscept
viral
infect
might
import
consid
develop
futur
antivir
therapi
line
larg
overlap
influenza
viru
type
ii
marker
antigen
stain
detect
viral
gene
express
type
pneumocyt
suggest
infect
advanc
beyond
earli
stage
cell
season
influenza
virus
previous
shown
primarili
attach
fix
lung
section
cell
morpholog
resembl
type
pneumocyt
address
whether
initi
viral
replic
cycl
interestingli
type
cell
report
becom
infect
influenza
viru
purif
lung
tissu
clearli
work
requir
resolv
question
observ
lung
organ
cultur
type
ii
pneumocyt
also
present
infect
lung
specimen
also
detect
viral
antigen
alveolar
macrophag
regardless
strain
test
find
consist
recent
report
show
isol
alveolar
macrophag
suscept
infect
human
avian
influenza
virus
nevertheless
macrophag
constitut
minor
fraction
infect
cell
like
contribut
great
extent
viru
growth
may
well
contribut
product
cytokin
season
virus
induc
moder
cytokin
respons
indic
virus
avoid
suppress
vigor
activ
epitheli
lung
tissu
also
pandem
viru
provok
weak
cytokin
respons
confirm
previou
report
involv
infect
human
macrophag
dendrit
cell
primari
alveolar
cell
low
level
cytokin
induct
may
contribut
success
propag
rapid
spread
viru
human
viru
replic
least
well
season
viru
induc
strong
cytokin
respons
resid
alveolar
cell
human
lung
explant
recruit
immun
cell
absent
ex
vivo
infect
model
like
pronounc
cytokin
induct
infect
patient
alreadi
initi
level
infect
alveolar
cell
interestingli
lowpathogen
avian
viru
also
trigger
strong
cytokin
respons
lung
explant
despit
poor
viral
growth
find
indic
viru
either
produc
high
amount
rna
lead
enhanc
activ
intracellular
receptor
control
cytokin
induct
ligat
avian
receptor
determin
provid
signal
express
cytokin
gene
latter
possibl
would
line
recent
find
demonstr
equal
even
higher
concentr
lung
mice
infect
lowpathogen
avian
viru
compar
viru
furthermor
ramo
et
al
recent
show
avian
receptor
bind
prefer
contribut
strong
cytokin
induct
variou
human
cell
precis
reason
current
unclear
classic
swine
viru
trigger
comparison
low
level
cytokin
secret
thu
poor
growth
anim
influenza
viru
human
lung
necessarili
caus
strong
cytokin
induct
may
involv
viral
andor
cellular
factor
identif
type
ii
pneumocyt
common
target
cell
influenza
virus
select
support
replic
human
highli
pathogen
avian
strain
abil
initi
cytokin
respons
highlight
valu
human
lung
organ
cultur
provid
insight
pathophysiolog
process
whether
permiss
human
lung
tissu
given
influenza
viru
depend
inher
replic
properti
type
ii
pneumocyt
specif
adapt
withstand
induc
innat
respons
combin
thereof
remain
determin
one
keep
mind
ex
vivo
anim
model
complet
reproduc
complex
structur
immunolog
respons
human
respiratori
tract
nevertheless
experiment
find
obtain
studi
close
mirror
clinic
patholog
observ
therefor
allow
detail
investig
regard
factor
speci
adapt
innat
immun
respons
therapeut
intervent
futur
analys
